Brief: Diamyd Medical To Fully Subscribe For Its Pro Rata Share In NextCell Pharma

Diamyd Medical AB

20/11/2020 07:49

Nov 20 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL WILL FULLY SUBSCRIBE FOR ITS PRO RATA SHARE
IN
NEXTCELL PHARMA
    * WILL INVEST ITS PRO RATA SHARE CORRESPONDING TO
APPROXIMATELY
SEK 19.3 MILLION IN A RIGHTS ISSUE IN ASSOCIATED COMPANY
NEXTCELL PHARMA AB
    * DIAMYD MEDICAL'S BOOK VALUE OF HOLDING IN NEXTCELL PHARMA
AFTER
INVESTMENT INCREASES FROM APPROXIMATELY SEK 11.7 MILLION TO
APPROXIMATELY SEK 30.9 MILLION

Source text for Eikon:  ID:nWkr97PWdf 
Further company coverage:  DMYDb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))